This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Early Registration Savings Deadline Expires In:

  • 00
  • 00
  • 00
  • 00
Delivered as a Hybrid Event from March 14-17, 2022
Attend In-Person or 100% Digitally!San Diego Convention Center, San Diego, California



Explore the future of Bioprocess with MilliporeSigma. Be sure to join our sessions to learn more about: 

  • Reducing steps and increasing throughput for your seed train
  • Insights on the path from research to commercialization for Gene Therapy
  • Biopharma industry's current AI maturity level and future applications
  • Use of advanced analytics in identifying outlier batches

Don't miss our technical posters featured in the program:

  • Strategies for Clarifying Harvest Feed Streams in Viral Vector Bioprocessing
  • Novel Rapid Molecular Technologies for Biosafety Testing

Be sure to visit our showcase pages: 

  • Bioprocessing 4.0 to learn more about how we can converge, intensify and evolve together
  • Cell and Gene Therapy to see how you can draw on our experience to bring your gene therapy to life


MilliporeSigma, a life science leader, is a business of Merck KGaA, Darmstadt, Germany.